A bill for an act relating to the definition of medical cannabidiol.

This bill (SF 163) updates Iowa's legal definition of "medical cannabidiol" to explicitly include specific product forms: oral (tablets, capsules, liquids, tinctures, sublingual), topical (gels, creams, lotions, patches), and limited inhalable forms (nebulizable, vaporizable dried cannabis). It directly affects patients using medical cannabis products and healthcare providers dispensing them by clarifying which cannabis-based products qualify under the state's medical program. The key change replaces the previous definition with a detailed list of permitted forms, including whole plant extracts and resins. This provides legal clarity for the medical cannabis program without altering eligibility or access rules.